ID

27240

Beschreibung

Standard Neoadjuvant Chemotherapy Versus Genomic Driven Chemotherapy in Patients With Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01180335

Link

https://clinicaltrials.gov/show/NCT01180335

Stichworte

  1. 04.11.17 04.11.17 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

4. November 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Breast Cancer NCT01180335

Eligibility Breast Cancer NCT01180335

Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
invasive breast cancer not eligible for conservative surgery
Beschreibung

Invasive carcinoma of breast | Ineligibility Breast-Conserving Surgery

Datentyp

boolean

Alias
UMLS CUI [1]
C0853879
UMLS CUI [2,1]
C1512714
UMLS CUI [2,2]
C0917927
her2 negative
Beschreibung

HER2 negative

Datentyp

boolean

Alias
UMLS CUI [1]
C4087376
amount of tumor cells >30% on hes slides
Beschreibung

Neoplastic Cell Percentage | Other Coding

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0597032
UMLS CUI [1,2]
C0439165
UMLS CUI [2]
C3846158
rin>6 and amount of rna>1 ug
Beschreibung

INR | RNA amount

Datentyp

boolean

Alias
UMLS CUI [1]
C0525032
UMLS CUI [2,1]
C0035668
UMLS CUI [2,2]
C1265611
no metastases
Beschreibung

Neoplasm Metastasis Absent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0027627
UMLS CUI [1,2]
C0332197
subject, age > 18 years and <65 years old
Beschreibung

Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
signed written informed consent
Beschreibung

Informed Consent

Datentyp

boolean

Alias
UMLS CUI [1]
C0021430
ps 0-1
Beschreibung

Performance status

Datentyp

boolean

Alias
UMLS CUI [1]
C1518965
no previous treatment for breast cancer
Beschreibung

Prior Therapy Absent Breast Carcinoma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C0332197
UMLS CUI [1,3]
C0678222
adequate organ function
Beschreibung

Organ function

Datentyp

boolean

Alias
UMLS CUI [1]
C0678852
fevg >50%
Beschreibung

Left ventricular ejection fraction

Datentyp

boolean

Alias
UMLS CUI [1]
C0428772
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
in situ carcinoma
Beschreibung

Carcinoma in Situ

Datentyp

boolean

Alias
UMLS CUI [1]
C0007099
multifocal cancers
Beschreibung

Multifocal breast carcinoma

Datentyp

boolean

Alias
UMLS CUI [1]
C2986662
her2+
Beschreibung

HER2/Neu Positive

Datentyp

boolean

Alias
UMLS CUI [1]
C2348909
presence of metastasis
Beschreibung

Neoplasm Metastasis

Datentyp

boolean

Alias
UMLS CUI [1]
C0027627
genomic testing not feasible because of tumor cells <30%, rin<6, insufficient amount of rna
Beschreibung

Genomic screening Unsuccessful | Neoplastic Cell Percentage | INR | RNA Amount Insufficient

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2349866
UMLS CUI [1,2]
C1272705
UMLS CUI [2,1]
C0597032
UMLS CUI [2,2]
C0439165
UMLS CUI [3]
C0525032
UMLS CUI [4,1]
C0035668
UMLS CUI [4,2]
C1265611
UMLS CUI [4,3]
C0231180
organ dysfunction that contraindicates chemotherapy
Beschreibung

Organ dysfunction | Medical contraindication Chemotherapy

Datentyp

boolean

Alias
UMLS CUI [1]
C0349410
UMLS CUI [2,1]
C1301624
UMLS CUI [2,2]
C0392920

Ähnliche Modelle

Eligibility Breast Cancer NCT01180335

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Invasive carcinoma of breast | Ineligibility Breast-Conserving Surgery
Item
invasive breast cancer not eligible for conservative surgery
boolean
C0853879 (UMLS CUI [1])
C1512714 (UMLS CUI [2,1])
C0917927 (UMLS CUI [2,2])
HER2 negative
Item
her2 negative
boolean
C4087376 (UMLS CUI [1])
Neoplastic Cell Percentage | Other Coding
Item
amount of tumor cells >30% on hes slides
boolean
C0597032 (UMLS CUI [1,1])
C0439165 (UMLS CUI [1,2])
C3846158 (UMLS CUI [2])
INR | RNA amount
Item
rin>6 and amount of rna>1 ug
boolean
C0525032 (UMLS CUI [1])
C0035668 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
Neoplasm Metastasis Absent
Item
no metastases
boolean
C0027627 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
Age
Item
subject, age > 18 years and <65 years old
boolean
C0001779 (UMLS CUI [1])
Informed Consent
Item
signed written informed consent
boolean
C0021430 (UMLS CUI [1])
Performance status
Item
ps 0-1
boolean
C1518965 (UMLS CUI [1])
Prior Therapy Absent Breast Carcinoma
Item
no previous treatment for breast cancer
boolean
C1514463 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0678222 (UMLS CUI [1,3])
Organ function
Item
adequate organ function
boolean
C0678852 (UMLS CUI [1])
Left ventricular ejection fraction
Item
fevg >50%
boolean
C0428772 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Carcinoma in Situ
Item
in situ carcinoma
boolean
C0007099 (UMLS CUI [1])
Multifocal breast carcinoma
Item
multifocal cancers
boolean
C2986662 (UMLS CUI [1])
HER2/Neu Positive
Item
her2+
boolean
C2348909 (UMLS CUI [1])
Neoplasm Metastasis
Item
presence of metastasis
boolean
C0027627 (UMLS CUI [1])
Genomic screening Unsuccessful | Neoplastic Cell Percentage | INR | RNA Amount Insufficient
Item
genomic testing not feasible because of tumor cells <30%, rin<6, insufficient amount of rna
boolean
C2349866 (UMLS CUI [1,1])
C1272705 (UMLS CUI [1,2])
C0597032 (UMLS CUI [2,1])
C0439165 (UMLS CUI [2,2])
C0525032 (UMLS CUI [3])
C0035668 (UMLS CUI [4,1])
C1265611 (UMLS CUI [4,2])
C0231180 (UMLS CUI [4,3])
Organ dysfunction | Medical contraindication Chemotherapy
Item
organ dysfunction that contraindicates chemotherapy
boolean
C0349410 (UMLS CUI [1])
C1301624 (UMLS CUI [2,1])
C0392920 (UMLS CUI [2,2])

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video